OpenAlex
PricingAboutJobs
Log inGet started
Work

Combination targeted therapy with Janus kinase inhibition plus biologic agents in refractory JIA: an international multi-centre case series.

PubMed

Year: 2026
Type: article
Study design: Observational Study
Source: PubMed
DOI: 10.1093/rheumatology/keag633
Authors: Marcus Sim, Joshua Bennett, Barrak Almoosawi, Rawan Almubarak, Octavio Aragon Cuevas, Samantha Cooray, Jessica Fisher, Orla G Killeen, Jayne MacMahon, Joanne May, Irfan Nengroo, Nandita Pai, Lucy Paterson-Brown, Elizabeth Twynam-Perkins, Mark Wood
Institutions: Leeds General Infirmary, Great North Children's Hospital, Alder Hey Children's Hospital, Children's Health Ireland at Crumlin, Great Ormond Street Hospital, Addenbrooke's Hospital, Noah's Ark Children's Hospital for Wales, Nottingham University Hospitals NHS Trust, Royal Hospital for Children
Language: English

Topic: Autoimmune and Inflammatory Disorders Research
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: juvenile idiopathic arthritis, refractory arthritis, JAK inhibitors, biologic agents, combination targeted therapy, tofacitinib, tocilizumab, glucocorticoid reduction, disease activity, adverse events, pulmonary alveolar proteinosis, Still's disease
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W7225862024
FWCI:
Cites:
Cited by:
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms